Guizhou Xinbang Pharmaceutical Co.,Ltd.’s Net Profit Dropped 1.5% in First Half of 2022

Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 156 million yuan in the first half of 2022, down 1.5% year-on-year.

Meanwhile, the company posted 3.1 billion yuan in revenue, up 1.5% year-on-year.

At the end of the reporting period, it had 9.7 billion yuan in total assets and 2.8 billion yuan in total liabilities, with a liability-to-asset ratio of 29%.